p89c-Myb is not required for fetal or adult hematopoiesis

The c‐myb gene encodes two proteins, termed p75 and p89. Of these, the larger isoform is transcribed from an alternatively spliced message that contains an additional exon, exon 9A. Disruption of the c‐myb locus in mice results in embryonic lethality due to defective hematopoiesis and in the adult,...

Full description

Saved in:
Bibliographic Details
Published inGenesis (New York, N.Y. : 2000) Vol. 48; no. 5; pp. 309 - 316
Main Authors Baker, Stacey J., Kumar, Atul, Reddy, E. Premkumar
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.05.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The c‐myb gene encodes two proteins, termed p75 and p89. Of these, the larger isoform is transcribed from an alternatively spliced message that contains an additional exon, exon 9A. Disruption of the c‐myb locus in mice results in embryonic lethality due to defective hematopoiesis and in the adult, tissue‐specific inactivation of c‐myb in hematopoietic tissues blocks differentiation along several lineages. The c‐myb knock‐out mouse models described thus far result in the disruption of both the p75 and p89 isoforms, making it impossible to assign a definitive role to p89c‐Myb in development and hematopoiesis. We have therefore generated a null‐mutant mouse where exon 9A has been systemically deleted that results in the absence of only the p89‐myb transcript and protein. Unlike disruption of both forms of the c‐myb gene, loss of only the p89‐encoding isoform does not have any deleterious effects on mammalian hematopoiesis and development. genesis 48:309–316, 2010. © 2010 Wiley‐Liss, Inc.
Bibliography:istex:A9A8555BAAEF2777CEE5BE3973521647B116F711
ark:/67375/WNG-RFGJHZC5-H
National Institutes of Health National Heart, Lung, and Blood Institute - No. 5RO1HL085279
ArticleID:DVG20619
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present Address: Division of Oncology, Stanford University School of Medicine, 260 Campus Drive, Paolo Alto, CA 94305
ISSN:1526-954X
1526-968X
DOI:10.1002/dvg.20619